BMC Medical Education (Feb 2021)
Correction to: Understanding the key processes of excellence as a prerequisite to establishing academic centres of excellence in Africa
- Abebaw Fekadu,
- Claire Oppenheim,
- Tsegahun Manyazewal,
- Corey Nislow,
- Yimtubezinash Woldeamanuel,
- Asrat Hailu,
- Anteneh Belete,
- Dawit Wondimagegn,
- Charlotte Hanlon,
- Tsige Gebremariam,
- Asha Collins,
- Christopher J. Larson,
- Wondwossen Gebreyes,
- Eleni Aklilu,
- Adamson S. Muula,
- Sabina Mugus,
- Conor R. Caffrey,
- Mirutse Giday,
- Getnet Yimer,
- Gail Davey,
- Girmay Medhin,
- Eyasu Makonnen
Affiliations
- Abebaw Fekadu
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Claire Oppenheim
- Department of Psychiatry, Boston University, School of Medicine
- Tsegahun Manyazewal
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Corey Nislow
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Yimtubezinash Woldeamanuel
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Asrat Hailu
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Anteneh Belete
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Dawit Wondimagegn
- College of Health Sciences, Addis Ababa University
- Charlotte Hanlon
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Tsige Gebremariam
- Department of Pharmaceutics and Social Pharmacy, College of Health Sciences, Addis Ababa University
- Asha Collins
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Christopher J. Larson
- Development, Aging & Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute
- Wondwossen Gebreyes
- The Global One Health initiative, Ohio State University
- Eleni Aklilu
- Division of Clinical Pharmacology, Department of Laboratory of Medicine, Karolinska Institute
- Adamson S. Muula
- Department of Public Health, School of Public Health & Family Health, University of Malawi
- Sabina Mugus
- Department of Pharmacology, Muhimbili University of Health and Allied Sciences
- Conor R. Caffrey
- Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
- Mirutse Giday
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Getnet Yimer
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Gail Davey
- Global Health & Infection Department, Brighton and Sussex Medical School
- Girmay Medhin
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- Eyasu Makonnen
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University
- DOI
- https://doi.org/10.1186/s12909-021-02523-z
- Journal volume & issue
-
Vol. 21,
no. 1
pp. 1 – 1
Abstract
An amendment to this paper has been published and can be accessed via the original article.
